Published in Br J Clin Pharmacol on August 01, 1976
Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther (1974) 2.26
Application of salivary salicylate data to biopharmaceutical studies of salicylates. J Pharm Sci (1972) 2.10
Salivary excretion of paracetamol in man. J Pharm Pharmacol (1973) 1.93
Relationship between digoxin concentrations in serum and saliva. Clin Pharmacol Ther (1975) 1.38
Bio-availability of three formulations of glibenclamide. S Afr Med J (1989) 1.39
Cardiac glycoside poisoning involved in deaths from traditional medicines. S Afr Med J (1992) 1.37
Experience with the intensive care management of organophosphate insecticide poisoning. S Afr Med J (1981) 1.12
Acute poisoning with Jatropha curcas (purging nut tree) in children. S Afr Med J (1984) 0.99
Ethnic differences in response to beta 1-adrenoceptor blockade by propranolol. J Cardiovasc Pharmacol (1984) 0.98
The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers. Eur J Clin Pharmacol (1985) 0.97
A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants. Arch Dis Child (1998) 0.96
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. Br J Clin Pharmacol (1995) 0.94
Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase. Eur J Clin Pharmacol (1987) 0.92
The pharmacology of recombinant hirudin, a new anticoagulant. S Afr Med J (1990) 0.92
South African multicentre trial with Voltaren in osteo-arthritis of the knee. S Afr Med J (1974) 0.90
Caffeine in sport. Urinary excretion of caffeine in healthy volunteers after intake of common caffeine-containing beverages. S Afr Med J (1988) 0.88
Severe peripheral ischaemia during concomitant use of beta blockers and ergot alkaloids. Br Med J (Clin Res Ed) (1984) 0.88
Fatal suicidal ingestion of thioridazine. Clin Toxicol (1974) 0.87
Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. Arzneimittelforschung (1989) 0.86
The effects of forskolin eye drops on intra-ocular pressure. S Afr Med J (1987) 0.86
Unreliable drug histories, analgesics, and changes in renal function. S Afr Med J (1977) 0.86
Self-medication in a developing community. S Afr Med J (1984) 0.86
Does cimetidine alter the cardiac response to exercise and propranolol? S Afr Med J (1979) 0.85
A correlative study of serum digoxin levels and electrocardiographic measurements. S Afr Med J (1975) 0.85
Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations. S Afr Med J (1981) 0.85
Single and divided doses of penbutolol. Clin Pharmacol Ther (1979) 0.85
A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis. S Afr Med J (1974) 0.84
Chorea and psychiatric changes in organophosphate poisoning. A report of 2 further cases. S Afr Med J (1988) 0.84
Ethnic differences in beta-1-adrenoceptor sensitivity. S Afr Med J (1982) 0.84
Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. Int J Clin Pharmacol Biopharm (1977) 0.84
Pharmacokinetics of ramipril in the elderly. Am J Cardiol (1987) 0.83
Acute organophosphate poisoning presenting with choreo-athetosis. J Toxicol Clin Toxicol (1984) 0.82
Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. Am J Hypertens (1997) 0.82
Noradrenaline and local anaesthesia: a review of the literature and a clinical evaluation. J Dent Assoc S Afr (1987) 0.82
Comparative bio-availability of four formulations of furosemide. S Afr Med J (1985) 0.82
Attitudes of private medical practitioners towards package inserts and other drug information sources. S Afr Med J (1984) 0.81
Comparative pharmacokinetics of intravenous propranolol in black and white volunteers. J Cardiovasc Pharmacol (1985) 0.81
Subclinical impairment of colour vision in patients receiving ethambutol. Br J Clin Pharmacol (1986) 0.81
Ethnic differences in human lymphocytic cyclic AMP production after isoprenaline stimulation and propranolol blockade. Br J Clin Pharmacol (1985) 0.81
The effect of penbutolol on glomerular filtration. S Afr Med J (1981) 0.81
Developing a systems approach for Thaumatotibia leucotreta (Lepidoptera: Tortricidae) on 'Hass' avocado in South Africa. J Econ Entomol (2010) 0.81
Absolute bioavailability of a new high dose methylprednisolone tablet formulation. Int J Clin Pharmacol Ther (1994) 0.80
No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin. J Clin Pharmacol (1995) 0.80
Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Hum Toxicol (1983) 0.79
Pharmacokinetic aspects of the interaction between clobazam and cimetidine. Eur J Clin Pharmacol (1983) 0.79
The effect of fasting on total serum bilirubin concentrations. Br J Clin Pharmacol (1995) 0.79
Paracetamol overdose: protective effect of concomitantly ingested antimuscarinic drugs and codeine. Hum Toxicol (1983) 0.78
Severe mefenamic acid poisoning. A case report. S Afr Med J (1985) 0.78
Ibuprofen bio-availability. A comparison of Brufen and Inza. S Afr Med J (1986) 0.78
Epidemiology and control of schistosomiasis mansoni in communities living on the Cuando River floodplain of East Caprivi, Namibia. Ann Trop Med Parasitol (1995) 0.78
Letter: Ethyl alcohol: contamination of blood specimens. S Afr Med J (1976) 0.78
Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn. Eur J Clin Pharmacol (1996) 0.77
Lack of interaction between ramipril and simvastatin. Eur J Clin Pharmacol (1994) 0.77
Effects of tendamistate on postprandial plasma glucose, free fatty acid and triglyceride levels. S Afr Med J (1984) 0.77
Inhibition of starch absorption by tendamistate (an alpha-amylase inactivator). S Afr Med J (1983) 0.76
Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newborn. Lancet (1994) 0.76
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol. Arzneimittelforschung (1995) 0.76
No influence of pantoprazole on the pharmacokinetics of phenytoin. Int J Clin Pharmacol Ther (1995) 0.76
Multiple doses of trandolapril do not affect warfarin pharmacodynamics. S Afr Med J (1995) 0.76
Compliance in black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycaemic therapy. S Afr Med J (1991) 0.76
Inhibition of starch absorption by alpha-amylase inactivator given with food. Lancet (1983) 0.76
Availability of phendimetrazine from sustained and non-sustained action formulations. S Afr Med J (1975) 0.76
Geographical distribution and habitat preferences of the invader freshwater snail species Lymnaea columella (Mollusca: Gastropoda) in South Africa. Onderstepoort J Vet Res (1989) 0.76
Are pre-ejection period changes specific for inotropic effects? Eur J Clin Pharmacol (1987) 0.75
Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers. Br J Clin Pharmacol (1976) 0.75
Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans. J Clin Pharmacol (1990) 0.75
Effects of tendamistate (alpha-amylase inactivator) on starch metabolism. Br J Clin Pharmacol (1983) 0.75
Digitalis in clinical practice. S Afr Med J (1976) 0.75
Theophylline dose-concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal nuelin liquid in healthy volunteers. Chronobiol Int (1993) 0.75
Comparative bio-availability of theophylline whole and halved sustained-release tablets. S Afr Med J (1987) 0.75
Epilepsy and IgA deficiency--the effect of sodium valproate. S Afr Med J (1977) 0.75
Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures. Epilepsia (1994) 0.75
Oxprenolol plus ethanol causes no central nervous system depression--a comparison with lorazepam plus ethanol. S Afr Med J (1984) 0.75
Pharmacokinetics of aprotinin in two patients with chronic renal impairment. Br J Clin Pharmacol (1996) 0.75
The effects of felodipine on the pharmacokinetics of diazepam. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Effects of piretanide on potassium balance in hypertension. S Afr Med J (1985) 0.75
Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males. Arzneimittelforschung (1996) 0.75
Effects of tendamistate (an alpha-amylase inactivator), guar and placebo on starch metabolism. S Afr Med J (1984) 0.75
Pharmacodynamics and tolerability of low doses of tendamistate given with starch. S Afr Med J (1984) 0.75
Considerable cost savings through the analysis of pooled plasma samples in bioequivalence studies that fail to show bioequivalence. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Drug side-effects assessed in a 'naturalistic' setting. S Afr Med J (1977) 0.75
Bioequivalence of controlled-release calcium antagonists. Clin Pharmacokinet (1997) 0.75
Early experience with sodium valproate. S Afr Med J (1977) 0.75
Physostigmine and the adrenergic/antimuscarinic syndrome. A case report. S Afr Med J (1984) 0.75
Double-blind randomized cross-over trial of nocturnal elixir theophylline supplementation of a twice-daily sustained-release theophylline tablet formulation in asthmatic patients. Chronobiol Int (1993) 0.75
Epidural fentanyl in the management of postoperative pain. S Afr Med J (1986) 0.75
Digoxin, whole body potassium and the electrocardiogram. Eur J Clin Pharmacol (1978) 0.75
Drugs in sport. The first 5 years of testing in South Africa. S Afr Med J (1988) 0.75
Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Steady-state pharmacokinetics of phentermine extended-release capsules. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Importance of pharmacokinetics and dosage in digoxin maintenance therapy. A retrospective analysis of serum digoxin levels. S Afr Med J (1974) 0.75
No influence of pantoprazole on the pharmacokinetics of phenytoin. Int J Clin Pharmacol Ther (1996) 0.75
Dettol (chloroxylenol and terpineol) poisoning in a pregnant patient. A case report. S Afr Med J (1984) 0.75
Statistical significance versus clinical relevance. Part II. The use and interpretation of confidence intervals. S Afr Med J (1989) 0.75
Antagonism of diazepam by aminophylline in healthy volunteers. Anesth Analg (1984) 0.75
Effects of HOE 760 (histamine H2-receptor antagonist) on diazepam pharmacokinetics. S Afr Med J (1988) 0.75
Minimization--a method of obtaining comparable groups in clinical trials. S Afr Med J (1984) 0.75
[Serum levels of drugs--a valuable therapeutic aid or a costly academic game?]. S Afr Med J (1978) 0.75
Relative bioavailability of four controlled-release nifedipine products. Biopharm Drug Dispos (1994) 0.75
The metabolism of atropine in man. J Pharm Pharmacol (1986) 0.75
Ingestion of codeine and salicylic acid causing convulsions and coma. A case report. S Afr Med J (1984) 0.75